This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ahn, J.-H., and Hayward, G. S. (1997). The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71, 4599–4613.
Ahn, J.-H., Xu, Y., Jang, W.-J., Matunis, M., and Hayward, G. S. (2001). Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J. Virol. 75, 3859–3872
Ahn, J. H., Brignole, E., and Hayward, G. S. (1998). Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol. Cell. Biol. 18, 4899–4913.
Albrecht, T., Boldogh, I., Fons, M., Abubakar, S., and Deng, C. Z. (1990). Cell activation signals and the pathogenesis of human cytomegalovirus infection. Intervirology 31, 68–75.
Albrecht, T., Fons, M. P., Boldogh, I., Abubakar, I., Deng, S., and Millinoff, D. (1991). Metabolic and cellular effects of human cytomegalovirus infection. Transplant. Proc. 23, 48–55.
Alford, C. A., and Britt, W. J. (1990). Cytomegalovirus. In B. N. Fields, D. M. Knipe, et al (ed.), Raven Press, Ltd., New York, 1981–2010.
Angulo, A., Messerle, M., Griffiths, M., and Ghazal, P. (2000). In vitro and in vivo characterization of an enhancerless murine cytomegalovirus. 25th International Herpesvirus Workshop, Portland, OR.
Baldick, C. J., Marchini, A., Patterson, C. E., and Shenk, T. (1997). Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J. Virol. 71, 4400–4408.
Biron, K. K., Fyfe, J. A., Stanat, S. C., Leslie, K., Sorrell, J. A., and Lambe, C. U. (1986). A human cytomegalovirus mutant resistant to the nucleoside analog 9-[2-hydroxy-l-(hydroxymethyl)ethoxy]methylguanine(BW B759U) induces reduced levels of BW B759U triphosphate. Proc. Natl. Acad. Sci. USA 83, 8769–8773.
Boldogh, I., AbuBakar, S., and Albrecht, T. (1990). Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection. Science 247, 561–564.
Boldogh, I., AbuBakar, S., Deng, C. Z., and Albrecht, T. (1991). Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J. Virol. 65, 1568–1571.
Bonin, L. R., and McDougall, J. K. (1997). Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J. Virol. 71, 5861–5870.
Boyle, K. A., Pietropaolo, R. L., and Compton, T. (1999). Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell. Biol. 19, 3607–3613.
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., and Kouzarides, T. (1998). Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 239, 597–601.
Bresnahan, W. A., Albrecht, T., and Thompson, E. A. (1998). The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J. Biol. Chem. 273, 22075–22082.
Bresnahan, W. A., Boldogh, I., Chi, P., Thompson, E. A., and Albrecht, T. (1997). Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231, 239–247.
Bresnahan, W. A., Boldogh, I., Thompson, E. A., and Albrecht, T. (1996). Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224, 150–160.
Bresnahan, W. A., and Shenk, T. (2000a). Subset of viral transcripts packaged within human cytomegalovirus particles. Science 288, 2373–2376.
Bresnahan, W. A., and Shenk, T. E. (2000b). UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl. Acad. of Sci. USA 97, 14506–14511.
Bresnahan, W. A., Thompson, E. A., and Albrecht, T. (1997). Human cytomegalovirus infection results in altered Cdk2 subcellular localization. J. Gen. Virol. 78, 1993–1997.
Britt, W. J., and Mach, M. (1996). Human cytomegalovirus glycoproteins. Intervirology 39, 401–412.
Bruggeman, C. A., and van Dam-Mieras, M. C. E. (1991). The possible role of cytomegalovirus in atherogenesis. Progr. Med. Virol. 38, 1–26.
Brune, W., Menard, C., Heesemann, J., and Koszinowski, U. H. (2001). A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291, 303–305.
Castillo, J. P., Yurochko, A. D., and Kowalik, T. F. (2000). Role of human cytomegalovirus immediate-early proteins in cell growth control. J. Virol. 74, 8028–8037.
Chen, J., and Stinski, M. F. (2000). Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element. J. Virol. 74, 9845–9857.
Chen, Z., Knutson, E., Kurosky, A., and Albrecht, T. (2001). Degradation of p21Cip1 in cells productively infected with human cytomegalovirus. J. Virol. 75, 3613–3625.
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. (1993). Tymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849–852.
Colberg-Poley, A. M. (1996). Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci. Intervirology 39, 350–360.
Everett, R. D. (2000). ICP0 induces the accumulation of colocalizing conjugated ubiquitin. J. Virol. 74, 9994–10005.
Fish, K. N., Britt, W., and Nelson, J. A. (1996). A novel mechanism for persistence of human cytomegalovirus in macrophages. J. Virol. 70, 1855–1862.
Fortunato, E. A., Sommer, M. H., Yoder, K., and Spector, D. H. (1997). Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J. Virol. 71, 8176–8185.
Francoise, M. J., Jault, J., Ruchti, F., Fortunato, A., Clark, C., Corbeil, J., Richman, D. D., and Spector, D. H. (1995). Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69, 6697–6704.
Goldmacher, V. S., Bartle, L. M., Skaletskaya, A., Dionne, C. A., Nedersha, N. L., Vater, C. A., Han, J.-W., Lutz, R. J., Watanabe, S., McFarland, E. D. C., Kieff, E. D., Mocarski, E. S., and Chittenden, T. (1999). A cytomegalovirus-encoded mitrochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl Acad. Sci. USA 96, 12536–12541.
Greaves, R. F., and Mocarski, E. S. (1998). Detective growth correlates with reduced accumulation of viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72, 366–379.
Gribaudo, G., Riera, L., Lembo, D., De Andrea, M., Gariglio, M., Rudge, T. L., Johnson, L. F., and Landolfo, S. (2000). Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J. Virol. 74, 4979–4987.
Hagemeier, C., Caswell, R., Hayhurst, G., Sinclair, J., and Kouzarides, T. (1994). Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13, 2897–2903.
Hahn, G., Jores, R., and Mocarski, E. S. (1998). Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. 95, 3937–3942.
Harel, N. Y., and Alwine, J. C. (1998). Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2. J. Virol. 72, 5481–5492.
Hensel, G. M., Meyer, H. H., Buchman, I., Pommerehne, D., Schmolke, B., Plachter, B., Radsak, K., and Kern, H. F. (1996). Intracellular localization and expression of the human cytomegalovirus matrix protein pp71 (UL82): evidence for its translocation to the nucleus. J. Gen. Virol. 77, 3087–3097.
Ho, M. (1991). Cytomegalovirus: Biology and Infection. Plenum Publishing Corp., New York.
Hofman, H., Floss, S., and Stamminger, T. (2000). Covalent modification of the transactivator protein IE2-86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUM0-1 and hSMT3b. J. Virol. 74, 2510–2524.
Hofmann, H., Sindre, H., and Stamminger, T. (2000). Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein hDAXX. 25th International Herpesvirus Workshop, Portland, OR.
Homer, E. G., Rinaldi, A., Nicholi, M. J., and Preston, C. M. (1999). Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. J Virol. 73, 8512–8518.
Jault, F. M., Jault, J.-M., Ruchti, F., Fortunato, E. A., Clark, C., Corbeil, J., Richman, D. D., and Spector, D. H. (1995). Cytomegalovirus infection induces high levels of cyclins, phosphorylated RB, and p53, leading to cell cycle arrest. J. Virol. 69, 6697–6704.
Johnson, R. A., Huong, S. M., and Huang, E. S. (2000). Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J. Virol. 74, 1158–1167.
Kondo, K., Kaneshima, H., and Mocarski, E. S. (1994). Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91, 11879–11883.
Kurz, S., Steffens, H.-P., Mayer, A., Harris, J. R., and Reddehase, M. J. (1997). Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71, 2980–2987.
Kurz, S. K.., Rapp, M., Steffens, H.-P., Grzimek, N. K. A., Schmalz, S., and Reddehase, M. J. (1999). Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73, 482–494.
Liu, B., and Stinski, M. F. (1992). Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66, 4434–4444.
Lu Hayashi, M., Blankenship, C., and Shenk, T. (2000). Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA 97, 2692–2696.
Lu, M., and Shenk, T. (1996). Human cytomegalovirus infection inhibits cell cycle progression at multiple points including the transition from Gt to S. J. Virol. 70, 8850–8857.
Lu, M., and Shenk, T. (1999). Human cytomegalovirus UL69 protein induces cells to accumulate in Gt phase of the cell cycle. J. Virol. 73, 676–683.
Luo, R. X., Postigo, A. A., and Dean, D. C. (1998). Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473.
Mach, M., Kropff, B., Dal Monte, P., and Britt, W. (2000). Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73). J. Virol. 74, 11881–11892.
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–604.
Margolis, M. J., Pajovic, S., Wong, E. L., Wade, M., Jupp, R., Nelson, J. A., and Azizkhan, J. C. (1995). Interaction of the 72-kilodalton human cytomegalvirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol. 69, 7759–7767.
Massague, J. (1990). The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6, 597–641.
Meier, J. L., and Stinski, M. F. (1996). Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39, 331–342.
Melnick, J. L., Adam, E., and Debakey, M. E. (1993). Cytomegalovirus and atherosclerosis. Eur. Heart J. 14, 30–38.
Melnick, J. L., Hu, C., Burek, J., Adam, E., and DeBakey, M. E. (1994). Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42, 170–174.
Michelson, S., Alcami, J., Kim, S.-J., Danielpour, D., Licard, L., Bessia, C., Paya, C., and Virelizier, J.-L. (1994). Human cytomegalovirus infection induces production of transforming growth factor beta 1. J. Virol. 68, 5730–5737.
Michelson, S., Turowski, P., Picard, L., Goris, J., Landini, M. P., Topilko, A., Hemmings, B., Bessia, C., Garcia, A., and Virelizier, J. L. (1996). Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell drived PP2A. J. Virol. 70, 1415–1423.
Mocarski, E. S., Kemble, G. Lyle, J., Greaves, R. F. (1996). A deletion mutant in the human cytomegalovirus gene encoding IE1 491aa is replication defective due to a failure in autoregulation. Proc. Natl. Acad. Sci. USA 93, 11321–11326.
Muganda, P., Mendoza, O., Hernandez, J., and Qian, Q. (1994). Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J. Virol. 68, 8028–8034.
Muller, S., and Dejean, A. (1999). Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins correlating with nuclear body disruption. J. Virol. 73, 5139–5143.
Murphy, E. A., Streblow, D. N., Nelson, J. A., and Stinski, M. F. (2000). The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S-phase of permissive cells. J. Virol. 74, 7108–7118.
Navarro, L., Mowen, K., Rodems, S., Weaver, B., Reich, N., Spector, D., and David, M. (1998). Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol. Cell. Biol. 18, 3796–3802.
Nevins, J. R. (1992). E2F: a link between the Rb tumor suppressor and viral oncoproteins. Science 258, 424–429.
Pajovic, S., Wong, E. L., Black, A. R., and Azizkhan, J. C. (1997). Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol. and Cell. Biol. 17, 6459–6464.
Persoons, M. C. J., Daemen, M. J. A. P., Bruning, J. H., and Bruggeman, C. A. (1994). Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats: a clue to herpesvirus-associated atherogenesis? Cric. Res. 72, 214–220.
Poma, E. E., Kowalik, T. F., Zhu, L., Sinclair, J. H., and Huang, E.-S. (1996). The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 70, 7867–7877.
Rice, G. P. A., Schrier, R. D., and Oldstone, M. B. A. (1984). Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81, 6134–6138.
Rodems, S. M., Clark, C. L., and Spector, D. H. (1998). Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J. Virol. 72, 2697–2707.
Rodems, S. M., and Spector, D. H. (1998). Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J. Virol. 72, 9173–9180.
Salvant, B. S., Fortunato, E. A., and Spector, D. H. (1998). Cell cycle dysregulation by human cytomegalovirus: Influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J. Virol. 72, 3729–3741.
Sinclair, J., Baillie, J., Bryant, L., and Caswell, R. (2000). Human cytomegalovirus mediates cell cycle progression through G1 into early S phase in terminally differentiated cells. J. Gen. Virol. 81, 1553–1565.
Slobedman, B., and Mocarski, E. S. (1999). Quantitative analysis of latent human cytomegalovirus. J. Virol. 73, 4806–4812.
Soderberg-Naucler, C., Fish, K. N., and Nelson, J. A. (1997a). Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100, 3154–3163.
Soderberg-Naucler, C., Fish, K. N., and Nelson, J. A. (1997b). Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119–126.
Sommer, M. H., Scully, A. L., and Spector, D. H. (1994). Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J. Virol. 68, 6223–6231.
Song, Y.-J., and Stinski, M. F. (2001). Effect of the human cytomegalovirus IE86 protein on expression of cellular genes that regulate the cell cycle, biosynthetic enzymes for DNA synthesis, and the initiation of DNA synthesis: A gene microarray analysis. (Manuscript in preparation).
Span, A. H. M., Grauls, G., Bosman, F., Van Boven, C. P. A., and Bruggeman, C. A. (1992). Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 93, 41–52.
Spector, D. H. (1996). Activation and regulation of human cytomegalovirus early genes. Intervirology 39, 361–377.
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., and Epstein, S. E. (1994). Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391–394.
Stenberg, R. M. (1996). The human cytomegalovirus major immediate-early gene. Intervirology 39, 343–349.
Stinski, M. F. (1978). Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides. J. Virol. 26, 686–701.
Stinski, M. F. (1999). Cytomegalovirus promoter for expression in mammalian cells. In Gene Expression Systems: Using Nature for the Art of Expression, eds. J. M. Ferandez and J. P. Hoeffler, Academic Press, San Diego, CA, 211–233.
Streblow, D. N., Soderberg-Naucler, C., Vieiera, J., Smith, P., Wakabayashi, E., Ruchti, F., Mattison, K., Altschulaer, Y., and Nelson, J. A. (1999). The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99, 511–520.
Taylor-Wiedeman, J., Sissons, J. G., Borysiewicz, L. K., and Sinclair, J. H. (1991). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059–2064.
Trouche, D., and Kouzarides, T. (1996). E2F1 and El A 12S have a homologous activation domain regulated by Rb and CBP. Proc. Natl. Acad. Sci. 93, 11268–11273.
Tsai, H. L., Kou, G. H., Chen, S. C., Wu, C. W., and Lin, Y. S. (1996). Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J. Biol. Chem. 271, 3534–3540.
Weibusch, L., and Hagemeier, C. (2001). The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J. 20, 1086–1098.
Weibusch, L., and Hagemeier, C. (1999). Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G1. J. Virol. 73, 9274–9283.
Weinberg, R. (1995). The retinoblastoma and cell cycle control. Cell 81, 323–330.
Wilkinson, G. W., Kelly, C., Sinclair, J. H., and Richards, C. (1998). Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J. Gen. Virol. 79, 1233–1245.
Winkler, M., Rice, S. A., and Stamminger, T. (1994). UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J. Virol. 68, 3943–3954.
Xu, Y., Ahn, J.-H., Jang, W.-J., and Hayward, G. S. (2000). Covalent modification of human cytomegalovirus major immediate-early proteins IE1 and IE2 by small ubiquitin-related modifiers. 25th International Herpesvirus Workshop, Portland, OR.
Yoo, Y. D., Chiou, C.-J., Choi, K. S., Yi, Y., Michelson, S., Kim, S., Hayward, G. S., and Kim, S.-J. (1996). The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta 1 gene through an Egr-1 binding site. J. Virol. 70, 7062–7070.
Yurochko, A. D., Hwang, E.-S., Rasmussen, L., Keay, S., Pereira, L., and Huang, E.-S. (1997). The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kB during infection. J. Virol. 71, 5051–5059.
Yurochko, A. D., Kowalik, T. F., Huong, S. M., and Huang, E. S. (1995). Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol. 69, 5391–5400.
Zhu, H., Cong, J.-P., Mamtora, G., Gingeras, T., and Shenk, T. (1998). Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 14470–14475.
Zhu, H., Cong, J. P., and Shenk, T. (1997). Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. U.S.A. 94, 13985–13990.
Zhu, H., Shen, Y., and Shenk, T. (1995). Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69, 7960–7970.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Stinski, M.F., Song, YJ. (2002). Regulation of Cellular Genes by Cytomegalovirus. In: Holzenburg, A., Bogner, E. (eds) Structure-Function Relationships of Human Pathogenic Viruses. Springer, Boston, MA. https://doi.org/10.1007/0-306-47650-9_16
Download citation
DOI: https://doi.org/10.1007/0-306-47650-9_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46768-4
Online ISBN: 978-0-306-47650-1
eBook Packages: Springer Book Archive